APA

Michelot J. M., Moreau M. F., Veyre A. J., Bonafous J. F., Bacin F. J., Madelmont J. C., Bussiere F., Souteyrand P. A., Mauclaire L. P. & Chossat F. M. (19930812). Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Chicago

Michelot J M, Moreau M F, Veyre A J, Bonafous J F, Bacin F J, Madelmont J C, Bussiere F, Souteyrand P A, Mauclaire L P and Chossat F M. 19930812. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Harvard

Michelot J. M., Moreau M. F., Veyre A. J., Bonafous J. F., Bacin F. J., Madelmont J. C., Bussiere F., Souteyrand P. A., Mauclaire L. P. and Chossat F. M. (19930812). Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). : Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

MLA

Michelot J M, Moreau M F, Veyre A J, Bonafous J F, Bacin F J, Madelmont J C, Bussiere F, Souteyrand P A, Mauclaire L P and Chossat F M. Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide). : Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 19930812.